XML 77 R65.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting - Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended
May 30, 2020
Jun. 01, 2019
Segment Reporting    
Revenues $ 6,027,376 $ 5,372,589
Gross Profit 1,198,319 1,126,723
Adjusted EBITDA from continuing operations 107,392 110,347
Additions to property and equipment and intangible assets 39,174 49,191
Retail Pharmacy    
Segment Reporting    
Revenues 4,123,271 3,864,808
Operating segments | Retail Pharmacy    
Segment Reporting    
Revenues 4,123,271 3,864,808
Gross Profit 1,081,536 1,030,495
Adjusted EBITDA from continuing operations 62,982 84,008
Additions to property and equipment and intangible assets 36,607 44,244
Operating segments | Pharmacy Services    
Segment Reporting    
Revenues 1,977,246 1,566,292
Gross Profit 116,783 96,228
Adjusted EBITDA from continuing operations 44,410 26,339
Additions to property and equipment and intangible assets 2,567 4,947
Intersegment elimination    
Segment Reporting    
Revenues $ (73,141) $ (58,511)